Aug 2026· Nature Communications· Vol 17· 1 citation· 48 references
Medicine
TL;DR
The authors analyse national regulations and propose the SynBioxAI regulatory interoperability toolkit (RIOT), a practical, seven-lens institutional framework that gives research institutions the capacity to navigate regulatory divergence efficiently and transparently.
Abstract
The convergence of synthetic biology, artificial intelligence (AI), and automation (SynBioxAI) creates research activities that simultaneously engage biosecurity, AI governance, export control, and data sovereignty frameworks – none of which are designed for convergent science. We conduct a comprehensive cross-jurisdictional analysis of this regulatory landscape across sixteen nations, identifying critical ambiguities where novel SynBioxAI objects fall between established regulatory categories. Through seven realistic collaboration scenarios, we demonstrate that regulatory friction is multiplicative rather than additive. We propose the SynBioxAI Regulatory Interoperability Toolkit (RIOT): a practical, seven-lens institutional framework that gives research institutions the capacity to navigate regulatory divergence efficiently and transparently. The convergence of synthetic biology, AI, and automation creates new challenges for regulatory frameworks. In this Perspective, the authors analyse national regulations and propose the SynBioxAI regulatory interoperability toolkit to give research institutes the capacity to navigate divergent regulatory landscapes.
This paper intends to offer a feasible pathway for strengthening biosecurity governance in Africa hence helping support responsible scientific innovation while addressing the evolving risks of bio-digital convergence.
Keletso Masisi, M. Amougou, Ilodia Amilcar Zacarias et al.· Frontiers in Bioengineering...· 0 citations
Comprehensive bibliometric analyses reveal that a robust connection between diverse catalytic fields and emerging AI tools remains unestablished, creating a substantial disparity in advancement rates compared to other scientific domains.
Samuel Villanueva, Lisbeth Mendoza, Paulino Betancourt et al.· Discover Chemistry· 0 citations
Digital transformation in pharmaceutical regulatory affairs is accelerating as global submissions grow in complexity and traditional document-based workflows reach their limits. Artificial intelligence (AI), particularly natural language processing (NLP), is increasingly being explored to support regulatory data manage...
Inês Lucas, João Sousa, C. Vitorino· AAPS Journal· 0 citations
It is argued for defense-in-depth governance that links capability thresholds to proportionate responsibilities across the biological AI ecosystem, reducing high-consequence risk while preserving beneficial use.
Candace S. Y. Chan, Aris Karatzikos, I. Georgakopoulos-Soares· 0 citations
Artificial intelligence (AI) is reshaping materials discovery into a more integrated pipeline by combining data generation, surrogate prediction, and, in selected settings, closed‐loop experimentation at an unprecedented rate. However, the institutional mechanisms needed to govern reproducibility, interoperability, a...
Richard I. Harry, Shan-Shan Mei, Dean W. Ball· Advanced Materials & Technol...· 0 citations
Chemical engineering has evolved by adapting to available tools - from empirical correlations to simulation platforms and high-throughput experimentation. Each transition reshaped what was computationally and experimentally affordable, determining which problems received attention. Artificial intelligence introduces a...
Jasmine J, Amgad S. Moussa· Chimia (Basel)· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.